Antibody specific for CLEC14A and uses thereof
AssigneeScripps Korea Antibody Institute
InventorsSuk Mook Lee, Min kyoung Ki, Mee Hyun Jeoung, Jong Rip Choi
Life of this patent
Estimating the term…
Loading patent…
AssigneeScripps Korea Antibody Institute
InventorsSuk Mook Lee, Min kyoung Ki, Mee Hyun Jeoung, Jong Rip Choi
Estimating the term…
Provided is an antibody specifically binding to the CTLD (C-type lectin like domain) of clec14a (C-type lectin domain family 14, member A), a method for preparing the antibody, a composition for suppressing angiogenesis comprising the antibody, a method for suppressing angiogenesis by administering the antibody or the composition, a composition for preventing or treating cancer comprising the antibody, a method for treating cancer by administering the antibody or the composition, a composition for diagnosing cancer comprising the antibody, a kit for diagnosing cancer comprising the composition, a method for diagnosing cancer using the composition, a composition for suppressing angiogenesis comprising a material for inhibiting expression of clec14a, a kit for angiogenesis comprising the composition, a method for suppressing angiogenesis or treating cancer using the composition, and the use of the CTLD of clec14a as an epitope for an antibody suppressive of angiogenesis.
An antibody, binding specifically to CTLD (C-type lectin like domain) of clec14a (C-type lectin domain family 14, member A), wherein the antibody comprises at least one selected from the group consisting of:
Dependencies are inferred from the claim text.